Skip to main content
19 April 2024
Last updated:
Thursday 18 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
European biotechs pause during Q3
Read more
Biotechs in Q2: For now, the trend is down
Read more
European biotechs mixed in quarter
Read more
Why pharma is paying a premium for assets
Read more
The case for optimism for Europe's biotech sector
Read more
2017 stock market review: Biotechs buoyed by share issues
Read more
Q3 2017 stock market review: gains and losses shared equally among biotechs
Read more
A phenotypic share analysis
Read more
European biotechs post modest Q2 gains
Read more
Q1 2017 stock market report: Biotechs climb to the top of the tree
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form